Enobia Pharma logo — company profile

Enobia Pharma

Founded 1997 Canada Montreal, Canada 8 employees Venture round Total: $160.65M Biotechnology, Health Care

General Information

Company Name Enobia Pharma
Founded Year 1997
Location Canada Montreal, Canada
Employees 8
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Enobia Pharma. To contact Enobia Pharma, visit enobia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Enobia Pharma compare?

A PDF of Enobia Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Enobia Pharma soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Enobia Pharma

Enobia Pharma is a Canadian biotechnology company founded in 1997, dedicated to developing therapies for serious genetic bone disorders with no approved treatments. Their lead product, ENB-0040, is a subcutaneous bone-targeted enzyme replacement therapy designed for the rare disease hyposphostasia. The company specializes in the industries of Biotechnology and Health Care. Enobia Pharma received a significant $40.00M in Venture Round investment on 08 August 2011. This substantial investment reflects both the potential for their innovative therapeutic approaches and the confidence of investors in their ability to address unmet medical needs within the field of genetic bone disorders.

Business keywords: Enobia, genetic bone disorders, therapies, ENB-0040, enzyme replacement therapy, hyposphosphatasia, subcutaneous, rare disease, tissue non-specific alkaline phosphatase, drug development, biopharmaceuticals

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $40.00M -
08 Aug 2011
Venture Round $15.00M -
01 Apr 2011
Series C $50.00M 4
OrbiMed, Lothian Partners +2
10 Aug 2009
Series B $40.10M 5
OrbiMed, CTI Life Sciences Fund +3
01 Aug 2007
Series A $15.55M 1
T2C2 Capital
18 Jan 2005

Enobia Pharma Alternatives & Competitors

View All Alternatives
Enobia Pharma vs

Developing new treatments for rare metabolic disorders

Debt Financing
27 employees
Biotechnology, Health Care
Enobia Pharma vs

Empowering Precision Therapies for Rare Neurological Disorders

Venture round
Biotechnology, Health Care
Enobia Pharma vs
StrideBio, Inc
StrideBio, Inc United States

The next evolution in gene therapy

Acquired
4 employees
Biotechnology, Health Care

FAQ About Enobia Pharma

Enobia develops therapies to treat serious genetic bone disorders for which there are no approved treatments. Our lead product in development, ENB-0040 (human recombinant tissue non-specific alkaline phosphatase), is a subcutaneous bone-targeted enzyme replacement therapy for the rare disease hyposp...
Enobia Pharma was founded in 1997.
Enobia Pharma is headquartered in Montreal, Canada.
Enobia Pharma operates in Biotechnology and Health Care. Its work centres on Enobia, genetic bone disorders, therapies and ENB-0040.
Enobia Pharma has approximately 8 employees.
Enobia Pharma has completed 5 funding rounds, raising a total of $160.65M. The latest funding stage is Venture round.
Top alternatives and competitors to Enobia Pharma include HemoShear Therapeutics, Alcyone Lifesciences, StrideBio, Inc, Aro Biotherapeutics, Travere Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Enobia Pharma and HemoShear Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Enobia Pharma, https://bouncewatch.com/company/enobia-pharma, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes